• Immediate breast reconstruction post-mastectomy

• All ages (17-76 yrs)

• High BMI (15.3-38.5)

• At all cancer stages (0-IV)

• Secondary/bilateral reconstruction patients

• Nipple-areolar preservation

Kaohsiung Medical University Hospital Plastic Surgery, led by Prof. Hsing-Tao Lin, built the "Restoring Curves, Renewing Body" immediate breast reconstruction service with Transverse Rectus Abdominis Myocutaneous (TRAM) flap post-mastectomy. Refined and precise original surgery with excellent team collaboration ensures flap blood supply, 100% surgical success, no patient selection (BMI 15.3-38.5 avg 23.1, all cancer stages I-IV, ages 17-76, secondary, and bilateral reconstructions all accepted). From Feb 1997 to June 2014, across KMUH, KMU-Kangshan, KMU-Hsiao Kang, and Chang Gung system (4 hospitals): 1,134 pedicled TRAM flap reconstructions—#1 in autologous reconstruction in Taiwan and Asia. 97.4% immediate; 6.1% bilateral; 11.0% unmarried; nipple-areolar preservation since 2004: 51.1% (344/673). Low complications: total flap loss 0%, partial loss 0.7%, post-op infection 0.9%, fat necrosis 3.6%, mild-moderate skin ischemia 4.6%, abdominal herniation 0.5%. Subsequent treatment only delayed 4 days (reconstruction 32.3 days vs non-reconstruction 28.6 days). Reconstruction rate 39.1% (vs USA SEER 16%, Canada 7.7%, Denmark 16.9%, UK 31%). Patient satisfaction 98.0% (808 patients); 94.4% would recommend. Endorsed by Academician Fu-Chan Wei as "Asia's first surgeon to complete 1,000 breast reconstructions."

• Refined, precise TRAM flap original technique

• 100% surgical success, no patient selection

• #1 in autologous reconstruction in Taiwan & Asia

• First in Asia to complete 1,000 reconstructions

• 51.1% nipple-areolar preservation

• 39.1% reconstruction rate leads Asia

• 1,134 cases (1997-2014)

• 97.4% immediate (1,104)

• 69 bilateral (6.1%)

• Nipple-areolar preservation 344/673 (51.1%)

• MRM+TRAM 41% vs MRM 59%

• 4-hospital collaboration

• 100% surgical success

• 0% total flap loss

• 0.7% partial flap loss

• 98.0% patient satisfaction

• 94.4% would recommend

• Only 4 days delay in subsequent treatment

• Post-op infection 0.9%

• Fat necrosis 3.6%

• Mild-moderate skin ischemia 4.6%

• Abdominal herniation 0.5%

• Avoids second anesthesia risk

• Inclusive across BMI, age, stage

• Patient self-rated satisfaction 98.0%

• 94.4% willing to share/recommend

• Discharge in 1 week

• Good aesthetic results (nipple-areolar)

• Stable patient emotions

• Saves cost & time, avoids second anesthesia

• First in Asia with 1,000+ reconstructions

• 9 international conference talks

• 11 international physicians visited

• 39.1% reconstruction rate exceeds USA SEER 16%, Canada 7.7%

• Higher than Denmark 16.9%, UK 31%

• Benchmarked vs Lang JE, Mioton LM, Albornoz CR literature

• Invited talks at 19 domestic teaching hospitals

• 6 domestic hospitals' physicians visited

• Significant contribution to breast cancer treatment

• Provides patients reconstruction option of hope

• Trains national plastic surgery talent

• Asian breast reconstruction exemplar